Disposable pipette tip
    71.
    发明公开
    Disposable pipette tip 失效
    Einmalig verwendbare Pipettenspitze。

    公开(公告)号:EP0148333A1

    公开(公告)日:1985-07-17

    申请号:EP84112251.8

    申请日:1984-10-11

    申请人: CETUS CORPORATION

    IPC分类号: B01L3/02

    CPC分类号: B01L3/0279

    摘要: A disposable pipette tip (10) is formed for automatic installation and removal with low friction between the tip and pipette body (16) and a predetermined distance from the pipette body end (19) and the tip intake/discharge opening (12). The tip has a conical section (11) whose small end defines the tip intake/discharge opening and a cylindrical collar (14) that receives the pipette body. The tip is formed with an internal pipette seat (17) at the junction of the conical section and cylindrical collar so that the distance between the tip inlet/discharge opening and the pipette body end is fixed. The cylindrical collar also has a circumferential sealing rib (30) axially spaced from the pipette seat to form an air seal to account for manufacturing tolerances in the tip's cylindrical portion as to both diameter and roundness while maintaining low friction for installation and removal.

    摘要翻译: 形成一次性吸头(10),用于自动安装和移除尖端和移液管本体(16)之间的低摩擦力并与吸液管本体端部(19)和尖端进入/排出口(12)预定距离。 尖端具有锥形部分(11),其小端限定尖端进入/排出口和容纳移液管主体的圆柱形套环(14)。 尖端在锥形部分和圆柱形套环的接合部处形成有内部移液管座(17),使得尖端入口/排出口与移液管主体端部之间的距离是固定的。 圆柱形套环还具有与移液器座轴向间隔开的周向密封肋(30),以形成空气密封,以便在直径和圆度两者之间考虑尖端圆柱形部分中的制造公差,同时降低用于安装和拆卸的低摩擦力。

    Pharmaceutical and veterinary preparations of cystein-125-depleted muteins of Interleukin-2 and their production
    73.
    发明公开
    Pharmaceutical and veterinary preparations of cystein-125-depleted muteins of Interleukin-2 and their production 失效
    药物和白细胞介素-2的兽医产品,已经在半胱氨酸125被替换为(突变蛋白),以及它们的制备。

    公开(公告)号:EP0109748A1

    公开(公告)日:1984-05-30

    申请号:EP83306221.9

    申请日:1983-10-13

    申请人: CETUS CORPORATION

    IPC分类号: C12N15/00 C12P21/02 A61K37/02

    摘要: The invention provides muteins of biologically active proteins such as IFN-B and IL-2 in which cysteine residues that are not essential to biological activity have been deleted or replaced with other amino acids to eliminate sites for intermolecular crosslinking or incorrect intramolecular disulfide bridge formation. These muteins may be made via bacterial expression of mutant genes that encode the muteins and have been synthesized from the genes for the parent proteins by oligonucleotide-directed mutagenesis.

    摘要翻译: 本发明提供了生物活性蛋白的突变蛋白:例如IFN-β和IL-2,其中半胱氨酸残基确实不是已被删除或用其它氨基酸取代,以消除分子间交联的或不正确的分子内二硫键形成位点至关重要的生物活性。 这些突变蛋白可通过突变体的基因的细菌表达制成并编码突变蛋白,并从基因通过寡核苷酸定向诱变的亲本蛋白质havebeen合成。

    INTERFERON-ALPHA 74
    75.
    发明公开
    INTERFERON-ALPHA 74 失效
    INTERFERON-ALPHA 74。

    公开(公告)号:EP0098864A1

    公开(公告)日:1984-01-25

    申请号:EP83900460.0

    申请日:1983-01-11

    申请人: CETUS CORPORATION

    发明人: INNIS, Michael A.

    IPC分类号: C07K14 A61K38

    摘要: New polypeptide, called IFN- alpha 74, produced by E.coli transformed with a newly isolated and characterized human IFN- alpha gene. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and regulation of production of cell-produced substances.

    INTERFERON-ALPHA 61
    76.
    发明公开
    INTERFERON-ALPHA 61 失效
    INTERFERON-ALPHA 61。

    公开(公告)号:EP0098863A1

    公开(公告)日:1984-01-25

    申请号:EP83900459.0

    申请日:1983-01-11

    申请人: CETUS CORPORATION

    发明人: INNIS, Michael A.

    IPC分类号: C07K14 A61K38

    摘要: A new polypeptide, called IFN- alpha 61, produced by E. coli transformed with a newly isolated and characterized human IFN- alpha gene is described. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and regulation of production of cell-produced substances.

    STABLE HIGH COPY NUMBER PLASMIDS, METHOD FOR THEIR FORMATION AND THEIR USE IN PROTEIN PRODUCTION
    78.
    发明公开
    STABLE HIGH COPY NUMBER PLASMIDS, METHOD FOR THEIR FORMATION AND THEIR USE IN PROTEIN PRODUCTION 失效
    稳定的高拷贝数,其形成方法及其在蛋白质生产中的使用

    公开(公告)号:EP0060045A3

    公开(公告)日:1983-08-24

    申请号:EP82300865

    申请日:1982-02-22

    申请人: CETUS CORPORATION

    CPC分类号: C12N15/70 C12N15/69

    摘要: The problem of producing stable DNA plasmids of high copy number may be solved by selecting mutants in which an altered repressor gene leads to high copy number replication. The plasmids are modifed by placing a suitable transcriptional "stop" signal after an inserted heterogenous gene so that the readthrough expression of the heterologous DNA will not continue into the replication primer strand. Deletions resulting from interference with replication primer strand transcription are thereby avoided.
    Such plasmids may be used to produce a desired protein by introducing them into a host microorganism and allowing the host to express phenotypically its genotype (including the plasmids).

    摘要翻译: 通过选择其中改变的阻遏物基因导致高拷贝数复制的突变体,可以解决产生高拷贝数的稳定DNA质粒的问题。 通过在插入的异源基因之后放置合适的转录“停止”信号来修饰质粒,使得异源DNA的读取表达不会继续进入复制引物链。 从而避免了由于干扰复制引物链转录而导致的缺失。 这样的质粒可用于通过将其引入宿主微生物并使宿主表达其基因型(包括质粒)来产生所需的蛋白质。

    HLA typing method and cDNA probes used therein
    79.
    发明公开
    HLA typing method and cDNA probes used therein 失效
    HLA类型方法和使用的CDNA探针

    公开(公告)号:EP0084796A3

    公开(公告)日:1983-08-10

    申请号:EP83100175

    申请日:1983-01-11

    申请人: CETUS CORPORATION

    发明人: Erlich, Henry A.

    IPC分类号: C12N15/00 C12Q01/68

    摘要: HLA typing based on restriction length polymorphism is carried out by: digesting an individual's HLA DNA with a restriction endonuclease that produces a polymorphic digestion pattern with HLA DNA; subjecting the digest to genomic blotting using a labeled cDNA hybridization probe that is complementary to an HLA DNA sequence involved in the polymorphism; and comparing the resulting genomic blotting pattern with a standard This technique may be adapted to make paternity or transplant or transfusion compatibility determinations or to make disease association correlations to diagnose diseases or predict susceptibility to diseases. Locus specific cDNA hybridization probes, particularly probes for genes of Class II loci (D and OR loci), for use in the typing procedure are described.

    HLA typing method and cDNA probes used therein
    80.
    发明公开
    HLA typing method and cDNA probes used therein 失效
    Verfahren zur Charakterisierung von HLA und die darin benutzten cDNS-Testmittel。

    公开(公告)号:EP0084796A2

    公开(公告)日:1983-08-03

    申请号:EP83100175.5

    申请日:1983-01-11

    申请人: CETUS CORPORATION

    发明人: Erlich, Henry A.

    IPC分类号: C12N15/00 C12Q1/68

    摘要: HLA typing based on restriction length polymorphism is carried out by: digesting an individual's HLA DNA with a restriction endonuclease that produces a polymorphic digestion pattern with HLA DNA; subjecting the digest to genomic blotting using a labeled cDNA hybridization probe that is complementary to an HLA DNA sequence involved in the polymorphism; and comparing the resulting genomic blotting pattern with a standard This technique may be adapted to make paternity or transplant or transfusion compatibility determinations or to make disease association correlations to diagnose diseases or predict susceptibility to diseases. Locus specific cDNA hybridization probes, particularly probes for genes of Class II loci (D and OR loci), for use in the typing procedure are described.

    摘要翻译: 基于限制性长度多态性的HLA分型是通过用限制性内切核酸酶消化个体的HLA DNA,其产生具有HLA DNA的多态性消化模式; 使用与涉及多态性的HLA DNA序列互补的标记的cDNA杂交探针对消化片进行基因组印迹; 并将得到的基因组印迹图案与标准物进行比较。 这种技术可以适应于做出亲子鉴定或移植或输血相容性测定,或者使疾病关联相关性诊断疾病或预测对疾病的易感性。 描述了用于敲入程序的特异性cDNA杂交探针,特别是用于II类基因座(D和DR基因座)的基因的探针。